Tezcat Biosciences
Updated: April 05, 2026
CEO - Craig Ramirez
Country: USA | Add Funding
Founded: 2018
Website: https://www.tezcat.co/
Tezcat Biosciences develops therapy that targets the rat sarcoma (RAS) mutation. RAS is the most common kind of oncogene, a gene that causes cancer when mutated, but it’s difficult to treat because it lacks binding pockets for drugs. Instead of trying to inhibit RAS directly, Tezcat’s technology targets the bulk nutrient-scavenging process these cancer cells rely on for survival. It delivers a therapeutic payload by turning the cancer’s own feeding mechanism into a Trojan horse.
Founded: 2018
Website: https://www.tezcat.co/
Tezcat Biosciences develops therapy that targets the rat sarcoma (RAS) mutation. RAS is the most common kind of oncogene, a gene that causes cancer when mutated, but it’s difficult to treat because it lacks binding pockets for drugs. Instead of trying to inhibit RAS directly, Tezcat’s technology targets the bulk nutrient-scavenging process these cancer cells rely on for survival. It delivers a therapeutic payload by turning the cancer’s own feeding mechanism into a Trojan horse.
